Neurooncology | sciencenewsnet.in

Breaking News

Potential of ginsenoside Rg1 to treat aplastic anemia via mitogen activated protein kinase pathway in cyclophosphamide-induced myelosuppression mouse model

Refining adipose-derived stem cell isolation for optimal regenerative therapy

Resilience and challenges: Evaluating the impact of stress conditions on mesenchymal stem cells across different passages

Melatonin-based priming of stem cells to alleviate oxidative stress

Effects of miR-214-5p and miR-21-5p in hypoxic endometrial epithelial-cell-derived exosomes on human umbilical cord mesenchymal stem cells

Efficacy of serum-free cultured human umbilical cord mesenchymal stem cells in the treatment of knee osteoarthritis in mice

Exosome-based strategy against colon cancer using small interfering RNA-loaded vesicles targeting soluble a proliferation-inducing ligand

Yes-associated protein-mediated melatonin regulates the function of periodontal ligament stem cells under oxidative stress conditions

Can We Avert the Looming Food Crisis of Climate Change?

Embedding Owner-Manager Values in the Small and Medium Sized Enterprise Context: A Lockean Conceptualisation

26 Nov, 2024

Dr. Antonio Iavarone Is Committed to Changing How We Treat Brain Tumors

October 27, 2022 sarah JonasFeature Expert

Antonio Iavarone, M.D., has made a decades-long commitment to finding better treatments for glioblastoma and other aggressive brain tumors. As the new deputy director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, he will have opportunities to do even more.